Cover Image
市場調查報告書

神經刺激設備世界市場:產品分類 (脊髓刺激療法 (SCS)、深腦刺激 (DBS)、迷走神經刺激 (VNS)、薦骨神經刺激 (SNS)、皮膚刺激設備 (CS) 等)、用途分類、地區分類未來預測 (2017∼2027年)

Neurostimulation Devices Market 2017-2027 - Forecasts by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators and Others), by Application and Geography

出版商 Visiongain Ltd 商品編碼 224394
出版日期 內容資訊 英文 178 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經刺激設備世界市場:產品分類 (脊髓刺激療法 (SCS)、深腦刺激 (DBS)、迷走神經刺激 (VNS)、薦骨神經刺激 (SNS)、皮膚刺激設備 (CS) 等)、用途分類、地區分類未來預測 (2017∼2027年) Neurostimulation Devices Market 2017-2027 - Forecasts by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators and Others), by Application and Geography
出版日期: 2017年08月21日 內容資訊: 英文 178 Pages
簡介

本報告針對全球神經刺激設備市場分析、提供產品概略與市場基本構造、主要市場促進、阻礙因素、整體市場動向預測 (今後11年)、產品分類、用途分類、地區分類詳細動向、主要企業檔案等。

第1章 分析概要

第2章 神經刺激設備市場概略

  • 神經刺激設備分類
  • 神經刺激設備是什麼?
  • 世界各國醫療機器許可、規範體制

第3章 神經刺激設備市場:促進、阻礙因素

  • 市場促進因素
    • 神經疾病患者數增加
    • 人口高齡化加速
    • 生活習慣變化與肥胖人口增加
    • 新興國家市場的多種市場機會
  • 市場阻礙因素
    • 面對持續增加的精神疾病患者的神經科醫生不足
    • 醫療制度、政策變革的不透明未來
    • 發展中國家的一次醫療基本設施不足與醫療保險制度的欠缺

第4章 全球神經刺激設備市場:產品分類預測 (今後11年)

  • 脊髓電刺激療法設備 (SCS)
  • 深腦刺激 (DBS)
  • 迷走神經刺激 (VNS)
  • 薦骨神經刺激 (SNS)
  • 皮膚刺激設備 (CS)
  • 其他

第5章 全球神經刺激設備市場:用途分類預測 (今後11年)

  • 癲癇
  • 疼痛管理
  • 聽力缺損
  • 大小便失禁
  • 胃輕癱
  • 帕金森氏症
  • 其他疾病、用途

第6章 全球神經刺激設備市場:地區分類預測 (今後11年)

  • 介紹
  • 地區分類市場區分
  • 地區分類市場佔有率預測
  • 北美市場 (美國、加拿大)
  • 歐洲市場 (德國、法國、英國、義大利、西班牙等)
  • 亞太地區市場 (日本、中國、ユ⑦Э等)
  • 其他國家市場 (RoW:拉丁美洲、中東、非洲)

第7章 神經刺激設備市場代表企業

  • Advanced Bionics, LLC
    • 概要
    • 財務分析
    • 產品檔案
    • 近年動向
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Cyberonics
  • Medtronic plc
  • Neuronetics, Inc.
  • Nevro Corp.
  • Cogentix Medical Inc
  • St. Jude Medical
  • NDI Medical, llc.
  • 其他受矚目企業

第8章 全球神經刺激設備市場:競爭環境

  • 新產品發售
  • 企業收購、事業協力/合作
  • 其他動向

第9章 結論

  • 神經刺激設備市場:整體未來展望
  • 神經刺激設備市場:用途分類未來展望
  • 神經刺激設備市場:設備分類未來展望

第10章 用語一覽

圖表一覽

分析目標企業、機關一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0227

Neurostimulation - our new study reveals trends, R&D progress, and predicted revenues

Where is the Neurostimulation market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 178-page report provides 102 tables, charts, and graphs, providing over 2900 unique datapoints. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Neurostimulation market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 6 Neurostimulation Products and 7 Neurostimulation Applications, each forecasted at a global, regional and national level.

Neurostimulation Software, by Product

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Cortical Stimulators
  • Others

Neurostimulation, by Application

  • Pain Management
  • Epilepsy
  • Urinary and Fecal Incontinence
  • Hearing Loss
  • Gastroparesis
  • Parkinson's Disease
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 10 leading national markets:

  • North America:
  • The US
  • Canada

image1

  • Europe:
  • Germany
  • The UK
  • Italy
  • Spain
  • France
  • Rest of Europe
  • APAC:
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • RoW:
  • Latin America
  • Middle East and Africa
  • Other Countries

The report also includes profiles and for some of the leading companies in the Neurostimulation market, with a focus on the Neurostimulation segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Neurostimulation will surpass $19bn in 2027, our work calculates. We predict strong revenue growth through to 2027. With increasing incidence of neurological diseases, the demand for neurostimulation devices is expected to increase significantly in the next few years.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Neurostimulation Market report helps you

In summary, our 178-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the Neurostimulation market and 2 different segmentations, with forecasts for 6 Products and 7 Applications at a Global, Regional and National level - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 6 regional and 10 key national markets - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa are forecasted, as well as the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, India,
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 companies involved in the Neurostimulation market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Neurostimulation market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Why You Should Read This Report
  • 1.2 How This Report Delivers
  • 1.3 Key Questions Answered by This Analytical Report Include:
  • 1.4 Who is This Report For?
  • 1.5 Methodology
    • 1.5.1 Primary Research
    • 1.5.2 Secondary Research
    • 1.5.3 Market Evaluation & Forecasting Methodology
  • 1.6 Frequently Asked Questions (FAQ)
  • 1.7 Associated Visiongain Reports
  • 1.8 About Visiongain

2. Introduction to the Neurostimulation Devices Market

  • 2.1 Classification of Neurostimulation Devices
  • 2.2 What are Neurostimulation Devices?
  • 2.3 Regulation of Medical Devices?
    • 2.3.1 The US Approval and Regulation System
    • 2.3.2 The EU Approval and Regulation System
    • 2.3.3 China Approval and Regulation System
    • 2.3.4 Japan Approval and Regulation System
    • 2.3.5 India Approval and Regulation System

3. Neurostimulation Devices Market: Drivers & Restraints

  • 3.1 Driving Factors
    • 3.1.1 Growing prevalence of neurological disorders
    • 3.1.2 Increasing Growth of Aging Population
    • 3.1.3 Changing Lifestyle and growing obesity
    • 3.1.4 Various opportunities from emerging markets
  • 3.2 Market Restraints
    • 3.2.1 Shortage of neurologists to treat an increasing number of neurologic patients
    • 3.2.2 Uncertain outcomes of changing healthcare policies
    • 3.2.3 Imposition of the medical device excise tax in the U.S.
    • 3.2.4 Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries

4. Global Neurostimulation Devices Market, By Product, 2017-2027

  • 4.1 Spinal Cord Stimulators Market Forecast 2017-2027
  • 4.2 Deep Brain Stimulators Market Forecast 2017-2027
  • 4.3 Vagus Nerve Stimulators Market Forecast 2017-2027
  • 4.4 Sacral Nerve Stimulators Market Forecast 2017-2027
  • 4.5 Cortical Stimulators Market Forecast 2017-2027
  • 4.6 Other Neurostimulation Devices Market Forecast 2017-2027

5. Global Neurostimulation Devices Market, By Application, 2017-2027

  • 5.1 Epilepsy Neurostimulation Devices Market Forecast 2017-2027
  • 5.2 Pain Management Neurostimulation Devices Market Forecast 2017-2027
  • 5.3 Hearing Loss Neurostimulation Devices Market Forecast 2017-2027
  • 5.4 Urinary and Fecal Incontinence Neurostimulation Devices Market Forecast 2017-2027
  • 5.5 Gastroparesis Neurostimulation Devices Market Forecast 2017-2027
  • 5.6 Parkinson's Disease Neurostimulation Devices Market Forecast 2017-2027
  • 5.7 Others Application Market Forecast 2017-2027

6. Global Neurostimulation Devices Market, By Region, 2017-2027

  • 6.1 Introduction
  • 6.2 Regional Breakdown of the Global Neurostimulation Devices Market
  • 6.3 How will Regional Market Shares Change to 2027?
  • 6.4 North America Neurostimulation Devices Market 2017-2027
    • 6.4.1 U.S. Neurostimulation Devices Market Forecast 2017-2027
    • 6.4.2 Canada Neurostimulation Devices Market Forecast 2017-2027
  • 6.5 Europe Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.1 Germany Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.2 France Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.3 UK Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.4 Italy Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.5 Spain Neurostimulation Devices Market Forecast 2017-2027
    • 6.5.6 Rest of Europe (RoE)
  • 6.6 Asia-Pacific Neurostimulation Devices Market Forecast 2017-2027
    • 6.6.1 Japan Neurostimulation Devices Market Forecast 2017-2027
    • 6.6.2 China Neurostimulation Devices Market Forecast 2017-2027
    • 6.6.3 India Neurostimulation Devices Market Forecast 2017-2027
    • 6.6.4 Rest of Asia-pacific Neurostimulation Devices Market Forecast 2017-2027
  • 6.7 Rest of the World Neurostimulation Devices Market Forecast 2017-2027
    • 6.7.1 Latin America Neurostimulation Devices Market Forecast 2017-2027
    • 6.7.2 Middle East & Africa Neurostimulation Devices Market Forecast 2017-2027

7. Leading Companies in the Neurostimulation Devices Market

  • 7.1 Advanced Bionics, LLC
    • 7.1.1 Overview
    • 7.1.2 Financials
    • 7.1.3 Product Portfolio
    • 7.1.4 Developments
  • 7.2 Boston Scientific Corporation
    • 7.2.1 Overview
    • 7.2.2 Financials
    • 7.2.3 Product portfolio
    • 7.2.4 Developments
  • 7.3 Cochlear Ltd.
    • 7.3.1 Overview
    • 7.3.2 Financials
    • 7.3.3 Product Portfolio
    • 7.3.4 Developments
  • 7.4 Cyberonics
    • 7.4.1 Overview
    • 7.4.2 Financials
    • 7.4.3 Products Portfolio
    • 7.4.4 Developments
  • 7.5 Medtronic plc
    • 7.5.1 Overview
    • 7.5.2 Financials
    • 7.5.3 Product Portfolio
    • 7.5.4 Developments
  • 7.6 Neuronetics, Inc.
    • 7.6.1 Overview
    • 7.6.2 Financials
    • 7.6.3 Product Portfolio
    • 7.6.4 Developments
  • 7.7 Nevro Corp.
    • 7.7.1 Overview
    • 7.7.2 Financials
    • 7.7.3 Product Portfolio
    • 7.7.4 Developments
  • 7.8 Cogentix Medical Inc
    • 7.8.1 Overview
    • 7.8.2 Financials
    • 7.8.3 Product Portfolio
    • 7.8.4 Developments
  • 7.9 St. Jude Medical
    • 7.9.1 Overview
    • 7.9.2 Financials
    • 7.9.3 Product Portfolio
    • 7.9.4 Developments
  • 7.10 NDI Medical, llc.
    • 7.10.1 Overview
    • 7.10.2 Product portfolio
    • 7.10.3 Developments
  • 7.11 Other Companies of Interest Neurostimulation Devices Market

8. The Global Neurostimulation Devices Market, Competitive Landscape

  • 8.1 New Product Launches
  • 8.2 Acquisitions, Collaborations, and Partnerships
  • 8.3 Other Developments

9. Conclusions

  • 9.1 Top Neurostimulation Devices Market
  • 9.2 Top Neurostimulation Devices Applications Market
  • 9.3 Top Nations Neurostimulation in the Devices Market

10. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 2.1 Neurostimulation Devices Market Segmentation
  • Figure 2.2 Stages of regulatory control
  • Figure 3.1 Neurostimulation Devices Market: Drivers and Restraints, 2017-202
  • Figure 3.2 Share of geriatric population, by region, 2010-2020
  • Figure 4.1 Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 4.3 Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 4.4 Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2017-2027
  • Figure 4.6 Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 4.7 Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.1 Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.6 Urinary and Fecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.7 Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.8 Parkinson's Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2017-2027
  • Figure 5.9 Other Neurostimulation Devices Markets by Region: Forecast ($m), 2017-2027
  • Figure 6.1 Neurostimulation Devices Markets by Region: Forecast ($m), 2016
  • Figure 6.2 North America Neurostimulation Devices Markets by Country (%), 2017
  • Figure 6.3 U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.4 Increasing Prevalence Rate In Canada By Chronic Diseases, 2001-2039
  • Figure 6.5 Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.6 Europe Neurostimulation Devices Markets by Country (%), 2017
  • Figure 6.7 Change in population structure in Germany, 1995-2015
  • Figure 6.8 Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.9 France Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.10 U.K. Population estimates and projections, 2010-2040
  • Figure 6.11 U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.12 Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.13 Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.14 Asia-Pacific Neurostimulation Devices Markets by Country (%), 2017
  • Figure 6.15 Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.16 Share of Aging population in total Chinese population, 2011-2016 (%)
  • Figure 6.17 China Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.18 India Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.19 Rest of the World Neurostimulation Devices Markets by Region (%), 2017
  • Figure 6.20 Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 6.21 Middle East and Africa Revenue Neurostimulation Devices Revenue ($m) and AGR (%) 2017-2027
  • Figure 7.1 Advanced Bionics: Recent Financials, 2014-2016
  • Figure 7.2 Boston Scientific Corporation: Recent Financials, 2014-2016
  • Figure 7.3 Cochlear: Recent Financials, 2014-2016
  • Figure 7.4 Cyberonics: Recent Financials, 2014-2016
  • Figure 7.5 Medtronic: Recent Financials, 2014-2016
  • Figure 7.6 Nevro Corp: Recent Financials, 2014-2016
  • Figure 7.7 St. Jude Medical: Recent Financials, 2013-2015
  • Figure 9.1 Top Neurostimulation Devices Market
  • Figure 9.2Top Neurostimulation Devices Applications
  • Figure 9.3 Top Nations in the Neurostimulation Devices Market

List of Tables

  • Table 4.1 Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.3 Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.4 Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.6 Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 4.7 Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.1 Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.6 Urinary and Fecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.7 Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.8 Parkinson's Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 5.9 Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.1 Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.2 North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.3 North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.4 North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.5 Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.6 Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.7 Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.8 Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.9 Asia-PacificNeurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.10 Asia-PacificNeurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.11 Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.12 Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 6.13 Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2017-2027
  • Table 7.1 Advanced Bionics Product Portfolio
  • Table 7.2 Advanced Bionics: Developments
  • Table 7.3 Boston Scientific Corporation: Product Portfolio
  • Table 7.4 Boston Scientific Corporation: Developments
  • Table 7.5 Cochlear Ltd.: Product Portfolio
  • Table 7.6 Cochlear Ltd.: Developments
  • Table 7.7 Cyberonics.: Product Portfolio
  • Table 7.8 Cyberonics: Developments
  • Table 7.9 Medtronic: Product Portfolio
  • Table 7.10 Medtronic: Developments
  • Table 7.11 Neuronetics: Product Portfolio
  • Table 7.12 Neuronetics: Developments
  • Table 7.13 Nevro Corp: Product Portfolio
  • Table 7.14 Nevro Corp: Developments
  • Table 7.15 Cogentix Medical: Product Portfolio
  • Table 7.16 Cogentix Medical: Developments
  • Table 7.17 St. Jude Medical: Product Portfolio
  • Table 7.18 St. Jude Medical: Developments
  • Table 7.19 NDI Medical: Product Portfolio
  • Table 7.20 NDI Medical: Developments
  • Table 7.21 Other Companies in the Neurostimulation Devices Market
  • Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
  • Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
  • Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
  • Table 7.21 Other Companies in the Neurostimulation Devices Market (continued)
  • Table 8.1 New Product Launches
  • Table 8.2 Acquisitions, Collaborations, and Partnerships
  • Table 8.3 Other Developments

Companies Listed

  • 480 Biomedical Inc.
  • Abbott Laboratories
  • Accellent
  • Advanced Bionics, LLC
  • Advanced Neuromodulation Systems
  • Allergan Plc
  • Anterios, Inc.
  • Argon Medical Devices Inc.
  • B. Braun
  • Baxter International, Inc.
  • Bayer AG
  • BioControl Medical (B.C.M) Ltd.
  • BIOMED CENTRAL LTD
  • Bionx Medical Technologies Inc.
  • Boston Scientific Corporation
  • Canadian Institutes of Health Research
  • Carestream Health, Inc.
  • Cochlear Ltd.
  • Codman & Shurtleff, Inc.
  • Cogentix Medical
  • Cyberonics Inc.
  • Deep Brain Innovations
  • Edwards Lifesciences Corp.
  • EndoStim Inc.
  • EnteroMedics Inc
  • GE HEALTHCARE LTD
  • Globus Medical, Inc.
  • Helius Medical Technologies, Inc.
  • Hitachi Health Care Manufacturing K.K.
  • Hologic, Inc.
  • Inspire Medical Systems Inc.
  • IntraPace, Inc.
  • Johnson & Johnson
  • Johnson & Johnson Medical Limited
  • LifeTech Scientific Corp.
  • LivaNova PLC
  • Mainstay Medical International Plc
  • MED-EL
  • Medtronic Plc
  • Medtronic Usa Inc.
  • Mindray Medical International Ltd.
  • Natus Medical, Inc.
  • NDI Medical LLC
  • Neurologica Corp.
  • NeuroMetrix, Inc.
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp
  • Nexstim Oyj
  • Penumbra, Inc.
  • Pfizer Inc.
  • Quest Diagnostics
  • Roche Holding AG
  • Royal Philips NV
  • Siemens AG
  • Smith & Nephew Plc
  • Soterix Medical Inc
  • St. Jude Medical
  • Stryker Corp.
  • Synapse Biomedical Inc.
  • Terumo Corp.
  • Tesla, Inc.
  • Toshiba Medical Systems Corporation
  • XOGRAPH HEALTHCARE LTD
  • Zimmer Biomet Holdings, Inc.

List of Organisations

  • American Academy of Neurology
  • Chinese Food & Drug Administration (CFDA)
  • Federal Interagency Forum on Aging-Related Statistics
  • Food & Drug Administration (US)
  • International Labour Organization (ILO)
  • Ministry of Health, Labor and Welfare (MHLW)
  • National Health Service (UK)
  • Parkinson's Disease Foundation
  • World Health Organisation (WHO)
Back to Top